Qiagen Plans Non-US Offering of Convertible Notes to Raise up to $300M

Mar 12, 2014

|

NEW YORK (GenomeWeb News) – Qiagen today announced plans to issue convertible notes in a private placement to raise up to $300 million in net proceeds.

The company also plans to buy back convertible notes due in 2026.

Qiagen said that it plans to repurchase up to the full $300 million of its outstanding 2026 convertible notes from non-US holders. It will use cash for the purchase, which will be priced based partly on today's variations in Qiagen's stock price.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

When the Ailment You're Studying Becomes Personal

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

Irish Genomics Initiative Looks to Expand Into Scotland

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

Another Source of Data for 23andMe

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

This Week in PLOS

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.

Main menu